Pulmonary drug delivery is a targeted drug delivery system which is precisely designed for the inhalation with the help of a device called Aerosol. It plays an important role in managing Asthma and COPD. On the basis of type the market is divided into nebulizer, metered dose inhaler, and dry powder inhaler. PDDS gives quick relief in obstructive pulmonary diseases and can be lifesaving in case of an asthmatic attack.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
- AstraZeneca plc
- Boehringer Ingelheim GmbH
- GlaxoSmithKline plc
- Novartis AG
- Koninklijke Philips N.V.
- 3M company
- Janssen (Johnson & Johnson)
- Clement Clarke International
- Briggs Healthcare
- Aerogen
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/2944
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- By product, the metered dose segment was the highest contributor to the market in 2020.
- On the basis of application, the asthma segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
- Depending on distribution channel, the retail pharmacies segment was the highest contributor to the market in 2020.
- Region wise, North America garnered the largest revenue share in 2020, however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/2944
The COVID-19 outbreak is anticipated to have a negative impact on the growth of the global pulmonary drug delivery systems market due to the implementation of lockdown in many countries. The COVID-19 pandemic has stressed the healthcare systems across the globe and has increased the need for the development of diagnostic instruments & treatment centers for people. The non-essential businesses are closed in many states such as university, restaurants, schools, shopping malls, and corporations. Thus, the COVID-19 pandemic is affecting the world, including the production and distribution of pharmaceuticals.
A huge number of clinics, hospitals across the globe, were restructured to increase the hospital capacity for the patients diagnosed with COVID-19, this may also lead to the growth of the hospitalized inhalation drug delivery market in future. The rise in number of hospitals will increase the diagnosis of disease. This has significantly contributed toward the growth of the global market.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com